» Articles » PMID: 35280178

Health Disparities and Differences in Health-Care-Utilization in Patients With Pulmonary Arterial Hypertension

Overview
Specialty Psychiatry
Date 2022 Mar 14
PMID 35280178
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Mental disorders are common in patients with pulmonary arterial hypertension (PAH) and contribute to impaired quality of life (QoL). The impact of mental disorders on access to health care, differences in clinical parameters and treatment in patients with PAH is unclear. In this study we sought to assess the impact of mental disorders and other health disparities on health-care-utilization in patients with PAH.

Methods: In a cross-sectional observational study of patients with PAH, mental disorders were characterized using a structed clinical interview. In addition, patients completed a self-administered questionnaire to assess QoL, symptoms of anxiety and depression, lifestyle-factors and educational status. Number of outpatient visits and communication events per year were calculated as a surrogate for health-care-utilization and were compared by the presence of mental disorder. Linear regression analysis was conducted to assess the impact on health-care-utilization.

Results: 117 patients with PAH participated in this study (70% female, median age 59 (interquartile range, 49-70) years). Significant differences between patients with or without mental disorders were found in anxiety, depression and QoL. There were no significant differences in clinical parameters. Patients with mental disorders had higher rates of outpatient visits and communication events than patients without mental disorders. Linear regression revealed a gain of 2.2 communication events per year in the presence of any mental disorders.

Conclusion: Mental disorders in patients with PAH are common and significantly affect health-care-utilization. This higher demand in patients with mental disorder needs to be addressed by physicians, psychiatrists and specialized nurses offering therapeutic strategies.

Citing Articles

Natural Language Processing and Social Determinants of Health in Mental Health Research: AI-Assisted Scoping Review.

Scherbakov D, Hubig N, Lenert L, Alekseyenko A, Obeid J JMIR Ment Health. 2025; 12():e67192.

PMID: 39819656 PMC: 11756842. DOI: 10.2196/67192.


Impression life with pulmonary hypertension: clinically relevant characteristics and quality of life among patients in Gansu, China.

Zhang J, Wen Y, Yin Y, Zhang Y, Zhang R, Zhang X Ther Adv Respir Dis. 2024; 18:17534666241246428.

PMID: 38676370 PMC: 11055475. DOI: 10.1177/17534666241246428.


Long-term outcomes in health-related quality of life influence chronic disease management in patients with pulmonary hypertension.

Li J, Xiao F, Liu H, Li H, Zhao Q, Sun C Front Cardiovasc Med. 2022; 9:1008253.

PMID: 36440006 PMC: 9685316. DOI: 10.3389/fcvm.2022.1008253.

References
1.
Park D, Fuge J, Meltendorf T, Kahl K, Richter M, Gall H . Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension. Front Psychiatry. 2021; 12:668647. PMC: 8263927. DOI: 10.3389/fpsyt.2021.668647. View

2.
Larisch A, Neeb C, de Zwaan M, Pabst C, Tiede H, Ghofrani A . [Mental distress and wish for psychosomatic treatment of patients with pulmonary hypertension]. Psychother Psychosom Med Psychol. 2014; 64(9-10):384-9. DOI: 10.1055/s-0034-1377013. View

3.
Olsson K, Meltendorf T, Fuge J, Kamp J, Park D, Richter M . Prevalence of Mental Disorders and Impact on Quality of Life in Patients With Pulmonary Arterial Hypertension. Front Psychiatry. 2021; 12:667602. PMC: 8200462. DOI: 10.3389/fpsyt.2021.667602. View

4.
Tammemagi M, Katki H, Hocking W, Church T, Caporaso N, Kvale P . Selection criteria for lung-cancer screening. N Engl J Med. 2013; 368(8):728-36. PMC: 3929969. DOI: 10.1056/NEJMoa1211776. View

5.
Sommer N, Ghofrani H, Pak O, Bonnet S, Provencher S, Sitbon O . Current and future treatments of pulmonary arterial hypertension. Br J Pharmacol. 2020; 178(1):6-30. DOI: 10.1111/bph.15016. View